Table 1. Patients’ Characteristics (n = 204).
| Characteristics | Number | % |
|---|---|---|
| Age at diagnosis (years) | ||
| Median (range) | 70.5 | |
| 65 - 70 | 102 | 50.0% |
| 71 - 75 | 57 | 27.9% |
| > 75 | 45 | 22.1% |
| Stage | ||
| Early-stage | 188 | 92.2% |
| Advanced-stage | 16 | 7.8% |
| Hormonal status | ||
| ER-positive | 155 | 75.9% |
| PR-positive | 148 | 72.5% |
| HER2 status | ||
| HER2-positive | 31 | 15.2% |
| HER2-negative | 165 | 80.9% |
| Unknown | 8 | 3.9% |
| Triple-negative | ||
| Yes | 33 | 16.2% |
| No | 171 | 83.8% |
| Positive family historya | ||
| Breast | 143 | 70.1% |
| Ovarian, pancreas, high-grade prostate | 34 | 16.7% |
| Nationality | ||
| Jordanians | 192 | 94.1% |
| Non-Jordanians | 12 | 5.9% |
aFirst, second or third-degree. ER: estrogen receptor; PR: progesterone receptor; HER2: human epidermal growth factor receptor 2.